MedTech company developing intelligent cardiac simulation software Epicardio is a MedTech company developing intelligent cardiac simulation software.
Epicardio Simulation™ is a real-time 3D electromechanical model of the heart, capable of reproducing complex arrhythmic states, responding to stimulation, such as pacing, ablation and drug administration, while generating accurate ECG/EGM signals in real-time. At Epicardio we commercialise eTraining apps for Cardiology, targeted to medical schools, hospitals and the cardiac devices industry. Epicardio apps are used globally by leading med schools such as Oxford, Cambridge, Karolinska, etc. Our industry partners include Schiller, Medtronic, Boston Scientific, Abbott, etc. We aim to become global leader in simulation-based medical eTraining and eDiagnosis support, improving access and reducing costs and patient risk. We are currently building a world-class range of intelligent simulation software to be sold to multiple international markets, and to accomplish this, we believe in creating a first-class working environment. If you would like to discuss opportunities with Epicardio, email us: contact (at) epicardio (dot) com.
07/01/2026
Our Epicardio Simulation global community in 2025 exceeded 11,700 users with more than 35,300 app accesses and more than 1hour average daily usage per user. User locations: 60% Europe, 20% North America, 11% Asia, 6% Oceania, 3% South America. https://www.epicard.io
Real-time 3D electromechanical model of the heart, capable of reproducing complex arrhythmic states, responding to stimulation, such as pacing, ablation and drug administration, while generating accurate ECG/EGM signals in real-time
23/12/2025
Epicardio Simulation - your virtual guide to mastering the intricacies of ECG, Pacing, and Cardiac EP. Enhance your skills with a subscription from: https://www.epicard.io/shop
17/12/2025
Epicardio Simulation wishes Happy Holidays and Merry Christmas. Your virtual guide to mastering the intricacies of ECG, Pacing, and Cardiac EP. Enhance your skills with a subscription from: https://www.epicard.io/shop
Proud to have completed the creation of VirtualCSP on behalf of Medtronic. This cutting-edge training program focuses on conduction system pacing and integrates state-of-the-art interactive 3D simulation technology, powered by Epicardio Simulation. Discover more on Medtronic Academy: https://www.medtronicacademy.com/en-xd/content/virtualCSP-simulator
17/10/2025
Join CHART Healthcare Academy, Inc. for an evening of EP Technology Updates with Epicardio Simulation - enhancing your learning journey with simulation. This FREE event offers an interactive experience designed to strengthen critical thinking andpractical application in cardiac EP and device pacing. 1.5 CEU. https://www.linkedin.com/events/learningwithsimulationfeaturing7383986819299848192/
Be the first to know and let us send you an email when Epicardio Simulation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Epicardio is a London UK based medical software company, developing and commercialising simulation-based eTraining and ePlanning software for Cardiology.
Released the 1st real-time 3D heart simulator app on iOS: “Intelligent Heart Sim - AFib”.
Our product range is targeted to medical schools, hospitals and corporate training for the cardiac device industry. Epicardio products are used globally by Schiller AG, Abbott, Boston Scientific, Cleveland Clinic, Oxford University, Barts Heart Centre, and many more.
Epicardio Simulation™ is a fully validated advanced cloud-based 3D simulation of the heart that shortens the cardiology learning curve.
- Enhances teaching in Cardiac Anatomy, ECG, Pacing and EP by providing leading edge simulation-based blended/self-learning and testing.
- Enables educators to deliver more content quicker, in a far more visually engaging way and to test students more efficiently.
- Helps students to fully master the complexity of the heart and take tests in their own time.
- Content can be customised to meet your specific needs.
Invented by Dr Vassilios Hurmusiadis and Dr Malcolm Finlay, it is based on proprietary real-time interactive 3D intelligent simulation technology and offers an unparalleled cloud-based tool for Cardiology.
Epicardio aims to become a global leader in simulation-based medical eTraining and eDiagnostics, improving access and reducing costs and patient risk. Supported by Innovate UK, the UK's innovation agency and match funding from private investment. We are currently building a world-class range of intelligent simulation-based products to be sold into multiple international markets, and to accomplish this, we believe in creating a first-class working environment. If you would like to discuss opportunities with Epicardio, email us: contact (at) epicardio (dot) com.
